Skip to main content
Salim Mujais, MD, Nephrology, Northbrook, IL

SalimKhalilMujaisMD

Nephrology Northbrook, IL

Physician

Dr. Mujais is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mujais' full profile

Already have an account?

  • Office

    2742 The Mews
    Northbrook, IL 60062
    Phone+1 847-224-5802

Summary

  • Dr. Salim Mujais is a nephrologist in Northbrook, IL. He received his medical degree from American University of Beirut Faculty of Medicine and has been in practice 39 years. He also speaks multiple languages, including French and Arabic. He is experienced in nephrology, transplant immunology, and autoimmune diseases.

Education & Training

  • American University of Beirut Faculty of Medicine
    American University of Beirut Faculty of MedicineClass of 1978
  • American University of Beirut
    American University of BeirutB.S., Biology/Chemistry, With Distinction, 1974

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1981 - 2017

Awards, Honors, & Recognition

  • Who's Who in America 2004
  • President's Award for Leadership, Renal Division Baxter Healthcare, 2002
  • Dean Award, Outstanding Basic Science Teacher Award Northwestern University Medical School, 1996
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Proarrhythmic safety of repeat doses of mirabegron in healthy subjects: a randomized, double-blind, placebo-, and active-controlled thorough QT study  
    Malik M, van Gelderen EM, Lee JH, Kowalski DL, Yen M, Goldwater R, Mujais SK, Schaddelee MP, de Koning P, Kaibara A, Moy SS, Keirns JJ, Clin Pharmacol Ther, 12/1/2012
  • Modern peritoneal dialysis: Concepts and approaches  
    Mujais S, Holmes C, Kidney Int, 1/1/2006
  • Glucose sparing in peritoneal dialysis: Implications and metrics  
    Holmes C, Mujais S, Kidney Int, 1/1/2006
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Non-Thrombogenic Surfaces
    Mujais SK, Proceedings of Symposium on Biomaterial, Krems, Austria, 1/1/1994

Press Mentions

  • Affinivax and Astellas Present Safety and Immunogenicity Data from Phase 2 Study of ASP3772, a Novel 24 Valent MAPS™ Vaccine for Streptococcus Pneumoniae
    Affinivax and Astellas Present Safety and Immunogenicity Data from Phase 2 Study of ASP3772, a Novel 24 Valent MAPS™ Vaccine for Streptococcus PneumoniaeJuly 12th, 2021
  • FDA Accepts for Priority Review the New Drug Application for Mirabegron for Oral Suspension and Supplemental New Drug Application for Myrbetriq® (Mirabegron) Tablets in Pediatric Patients
    FDA Accepts for Priority Review the New Drug Application for Mirabegron for Oral Suspension and Supplemental New Drug Application for Myrbetriq® (Mirabegron) Tablets in Pediatric PatientsJanuary 6th, 2021
  • FDA Fast-Tracks Therapy for Patients at Risk for Acute Kidney Injury After CABG/Valve Surgery
    FDA Fast-Tracks Therapy for Patients at Risk for Acute Kidney Injury After CABG/Valve SurgeryOctober 29th, 2019
  • Join now to see all

Other Languages

  • French, Arabic